Kwon Kihwan Professor
College of Medicine
- Medical Science Building A #709
- 02-2650-2640
Research Record
- A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin Frontiers in Cardiovascular Medicine, 2024, v.11, 1324203
- Scalable production of siRNA-encapsulated extracellular vesicles for the inhibition of KRAS-mutant cancer using acoustic shock waves Journal of Extracellular Vesicles, 2024, v.13 no.9, e12508
- Blood flow patterns switch VEGFR2 activity through differential S-nitrosylation and S-oxidation Cell Reports, 2023, v.42 no.11, 113361
- Clinical safety and effectiveness of the Genoss drug-eluting stent in real-world clinical practice Korean Journal of Internal Medicine, 2023, v.38 no.5, 683-691
- Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension Journal of Clinical Hypertension, 2023, v.25 no.5, 429-439
- Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial Journal of Clinical Hypertension, 2023, v.25 no.9, 817-827
- Performance of a Novel CT-Derived Fractional Flow Reserve Measurement to Detect Hemodynamically Significant Coronary Stenosis JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, v.38 no.32, e254
- A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy Clinical Hypertension, 2022, v.28, 40-40
- A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy Clinical Hypertension, 2022, v.28 no.1, 40
- Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial Clinical Therapeutics, 2022, v.44 no.4, 508-528
- Fluid Shear Stress Regulates the Landscape of microRNAs in Endothelial Cell-Derived Small Extracellular Vesicles and Modulates the Function of Endothelial Cells INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, v.23 no.3, 1314
- Potential application of biomimetic exosomes in cardiovascular disease: focused on ischemic heart disease BMB REPORTS, 2022, v.55 no.1, 30-38
- Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Protect Cardiomyocytes from Doxorubicin-Induced Cardiomyopathy by Upregulating Survivin Expression via the miR-199a-3p-Akt-Sp1/p53 Signaling Pathway INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, v.22 no.13, 7102
- Clinical impact of pre-hypertension on the risk of cancer in male and female subjects Scientific Reports, 2020, v.10 no.1, 9974
- Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia Journal of Clinical Hypertension, 2020, v.22 no.10, 1835-1845
- Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice KOREAN CIRCULATION JOURNAL, 2020, v.50 no.4, 317-327
- Validation of the diagnostic performance of 'HeartMedi V.1.0', a novel CT-derived fractional flow reserve measurement, for patients with coronary artery disease: a study protocol BMJ open, 2020, v.10 no.7, e037780
- Coxsackievirus and adenovirus receptor mediates the responses of endothelial cells to fluid shear stress EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, v.51, 144
- Coxsackievirus and adenovirus receptor mediates the responses of endothelial cells to fluid shear stress Experimental and Molecular Medicine, 2019, v.51, 1~15
- Extracorporeal shock waves protect cardiomyocytes from doxorubicin-induced cardiomyopathy by upregulating survivin via the integrin-ILK-Akt-Sp1/p53 axis Scientific Reports, 2019, v.9 no.1, 12149
- Blood flow characteristics of diabetic patients with complications detected by optical measurement BioMedical Engineering Online, 2018, v.17 no.1
- Fluid shear stress regulates the expression of Lectin-like oxidized low density lipoprotein receptor-1 via KLF2-AP-1 pathway depending on its intensity and pattern in endothelial cells Atherosclerosis, 2018, v.270, 76-88
- Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study PLOS ONE, 2018, v.13 no.11, e0208100
- Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder Scientific Reports, 2018, v.8 no.1, 14707
- Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: A nationwide cohort study in Korea European Heart Journal, 2017, v.38 no.34, 2599-2607
- Extracellular matrix-derived extracellular vesicles promote cardiomyocyte growth and electrical activity in engineered cardiac atria Biomaterials, 2017, v.146, 49-59
- Selective tubular activation of hypoxia-inducible factor-2α has dual effects on renal fibrosis Scientific Reports, 2017, v.7 no.1
- Discovery of novel peptides targeting pro-atherogenic endothelium in disturbed flow regions-Targeted siRNA delivery to pro-atherogenic endothelium in vivo Scientific Reports, 2016, v.6
- Ursodeoxycholic Acid (UDCA) exerts anti-Atherogenic effects by inhibiting RAGE signaling in diabetic atherosclerosis PLoS ONE, 2016, v.11 no.1
- Csk-Induced Phosphorylation of Src at Tyrosine 530 is Essential for H2O2-Mediated Suppression of ERK1/2 in Human Umbilical Vein Endothelial Cells SCIENTIFIC REPORTS, 2015, v.5
- Novel mechanism of gene transfection by low-energy shock wave SCIENTIFIC REPORTS, 2015, v.5
- Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow MOLECULES AND CELLS, 2015, v.38 no.10, 851-858
- Vascular Proteomics Reveal Novel Proteins Involved in SMC Phenotypic Change: OLR1 as a SMC Receptor Regulating Proliferation and Inflammatory Response PLOS ONE, 2015, v.10 no.8
- Effect of anemia correction on left ventricular structure and filling pressure in anemic patients without overt heart disease KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, v.29, 445-453
Courses
-
2025-1st
-
Cardiovascular System
- Subject No 37613Class No 01
- 2Year ( 3Credit , 68Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅰ
- Subject No 37641Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2024-1st
-
Cardiovascular System
- Subject No 37613Class No 01
- 2Year ( 3Credit , 68Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅰ
- Subject No 37641Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2023-2nd
-
Internal Medicine Clerkship I
- Subject No 37641Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
Medical Innovation and Women's Ventures Ⅰ
- Subject No 39192Class No 01
- 2Year ( 1Credit , 16Hour)
-
-
2023-1st
-
Cardiovascular System
- Subject No 37613Class No 01
- 2Year ( 3Credit , 68Hour)
- Major Requisite
-
Internal Medicine Clerkship I
- Subject No 37641Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2022-2nd
-
Internal Medicine Clerkship I
- Subject No 37641Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
Medical Innovation and Women's Ventures Ⅰ
- Subject No 39192Class No 01
- 2Year ( 1Credit , 16Hour)
-
-
2022-1st
-
Cardiovascular System
- Subject No 37613Class No 01
- 2Year ( 3Credit , 68Hour)
- Major Requisite
-
Internal Medicine Clerkship I
- Subject No 37641Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
Academic Background
YONSEI UNIVERSITY 의학박사(의학과)